Experimental model of glucocorticoid-induced insulin resistance

Acta Cir Bras. 2016 Oct;31(10):645-649. doi: 10.1590/S0102-865020160100000001.

Abstract

Purpose:: To evaluate metabolic effects in experimental model of glucocorticoid-induced insulin resistance.

Methods:: Twenty Wistar male rats were randomly divided into two groups, which were treated with intraperitoneally injected dexamethasone 1mg/Kg/day for ten days consecutively (Group D; n=10) and placebo (Group C; n=10). The variables analyzed were: from the first to the 10th day - body weight (before and after treatment); food and water daily consumption; on the 10th day - glycemia, insulinemia, HOMA-beta and HOMA-IR. The blood samples for laboratory analysis were obtained by intracardiac puncture. Also on the 10th day liver fragments were taken for analyzing glycogen and fattty.

Results:: Group D animals compared to group C had: weight reduction (g), (D=226.5±24.7 vs C=295.0±25.4; p=0.001); increased glycemia (mmol/l) (D=19.5±2.1 vs C=14.2±3.1; p=0.0001); diminished insulinemia (mU/l) (D=0.2±0.1 vs C=2.0±0.4; p=0.0001); reduced HOMA-β (D=0.2±0.1 vs C=4.2±1.7; p=0.0002); diminished HOMA-IR (D=0.2±0.1 vs C=1.3±0.4; p=0.0002). Histological examination of the liver showed that 100% of group D and none of group C had moderate fatty. (p=0.2).

Conclusion:: Animals treated with glucocorticoid, in this experimental model, expressed hyperglycemia, hypoinsulinism and decreased peripheral insulin sensitivity.

Publication types

  • Evaluation Study

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Body Weight
  • Dexamethasone / adverse effects*
  • Diabetes Mellitus / chemically induced
  • Disease Models, Animal
  • Glucocorticoids / adverse effects*
  • Homeostasis / drug effects
  • Hyperglycemia / chemically induced
  • Insulin Resistance*
  • Liver / drug effects
  • Male
  • Random Allocation
  • Rats, Wistar

Substances

  • Blood Glucose
  • Glucocorticoids
  • Dexamethasone